Siga Technologies (SIGA) Stock Price, News & Analysis

Company Overview

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on developing and supplying medical countermeasures for biological threats and emerging infectious diseases. The company’s principal product is TPOXX (tecovirimat), an antiviral treatment developed for smallpox. TPOXX is available in oral and intravenous formulations, with regulatory approvals supporting its use in the United States and certain international markets.

SIGA primarily serves government agencies, including the U.S. government, which has procured TPOXX for the Strategic National Stockpile and other public-health preparedness programs. The company also works with international governments and public-health organizations to support smallpox preparedness and response. In addition to government procurement, TPOXX may be made available for certain patients under applicable emergency-use or public-health protocols.

SIGA has historically focused its research and development activities on antiviral drugs and biodefense products. The company is headquartered in New York City and became a publicly traded company through its merger with PharmAthene in 2015. Phillip L. Gomez serves as chief executive officer. SIGA continues to concentrate on the development, regulatory support and supply of TPOXX and related medical countermeasures.

Key Stats

• Today's Range: $3.29 to $3.43
• 50-Day Range: $2.87 to $3.46
• 52-Week Range: $2.83 to $9.17
• Volume: 641,926 shs
• Average Volume: 629,765 shs
• Market Capitalization: $242.85 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Siga Technologies Stock Analysis - MarketRank™

Siga Technologies scored higher than 8% of companies evaluated by MarketBeat, and ranked 851st out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Siga Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Siga Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Siga Technologies is -67.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Siga Technologies is -67.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Siga Technologies has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.34% of the float of Siga Technologies has been sold short.

Short Interest Ratio / Days to Cover

Siga Technologies has a short interest ratio ("days to cover") of 5.51.

Change versus previous month

Short interest in Siga Technologies has recently increased by 5.05%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Siga Technologies does not currently pay a dividend.

Dividend Growth

Siga Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: N/A

News Sentiment

Siga Technologies has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Siga Technologies this week, compared to 1 article on an average week.

Search Interest

1 people have searched for SIGA on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Siga Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Siga Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.73% of the stock of Siga Technologies is held by insiders.

Percentage Held by Institutions

55.40% of the stock of Siga Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:SIGA
• CIK: 1010086
• Web: www.siga.com
• Phone: (212) 672-9100
• Fax: 212-697-3130
• Employees: 49
• Year Founded: 1995

Profitability

• EPS (Trailing Twelve Months): ($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $23.28 million
• Net Margins: -5.19%
• Pretax Margin: -10.27%
• Return on Equity: -1.55%
• Return on Assets: -1.32%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 21.72
• Quick Ratio: 16.48

Sales & Book Value

• Annual Sales: $94.57 million
• Price / Sales: 2.57
• Cash Flow: $0.34 per share
• Price / Cash Flow: 10.06
• Book Value: $2.78 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 71,850,000
• Free Float: 69,888,000
• Market Cap: $242.85 million
• Optionable: Optionable
• Beta: 1.04